Back to search
FDAFDA · Food and drugs·Recall number Z-0657-2024

Baxter Coseal Premix, Surgical Sealant, Product Codes: a) 934070; b) 934071; c) 934072

Published January 17, 2024 · Recall initiated: December 6, 2023

Summary

FDA records medical device Class II recall Z-0657-2024, published January 17, 2024 and initiated December 6, 2023. Recalling firm: Baxter Healthcare Corporation; Status: Ongoing; Lot: All serial numbers a) Product code 934070, UDI/DI 5413765404610; b) Product code 934071, UDI/DI 5413765404627; c) Product code 934072, have no UDI/DI. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Cardiovascular Surgery marketing brochure (US-AS46-220001) that was distributed for the products listed below contains inaccurate content that does not align with some of the products Instructions for Use (IFU) or Prescribing Information (PI).

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Baxter Healthcare Corporation
Distributor
US Nationwide distribution.
Lot
All serial numbers a) Product code 934070, UDI/DI 5413765404610; b) Product code 934071, UDI/DI 5413765404627; c) Product code 934072, have no UDI/DI.
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was Baxter Coseal Premix, Surgical Sealant, Product Codes: a) 934070; b) 934071; c) 934072 recalled?

Yes. FDA published recall Z-0657-2024 on January 17, 2024. Reported hazard: Cardiovascular Surgery marketing brochure (US-AS46-220001) that was distributed for the products listed below contains inaccurate content that does not align with some of the products Instructions for Use (IFU) or Prescribing Information (PI).

What should I do if I have this product?

Voluntary: Firm initiated · Letter